Clinical trial · Interventional
Ambient AI Clinical Trial
Evaluation of Abridge Ambient AI Technology Regarding Provider Burnout and Patient Satisfaction With the Clinical Encounter
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This is a single-site pragmatic randomized control trial studying the effect of ambient artificial intelligence (AI) scribes on the delivery of medical care to patients in the ambulatory setting. The study will last 150 days and include up to 65 providers in the intervention group. Providers will be recruited from three medical specialties, including primary care, oncology, and urology. The study will enroll providers and randomize them to an intervention group (access to the ambient AI scribe product) or a control group (routine patient care). Providers will be evaluated for burnout and task load measures through digital surveys at the beginning, middle, and end of the study. Provider electronic health record (EHR) usage data will also be evaluated for time spent documenting, time spent after hours on days with scheduled clinical care, and time between the start of the clinical encounter and signing it.
Conditions
Conditions (3)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Artificial Intelligence (AI) | — | UNRESOLVED | — |
| Physician Burnout | — | UNRESOLVED | — |
| Physician Work Environment | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Use of Ambient AI scribe tool on participant's mobile device | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Ambient AI scribe users
- description
- Participants in this arm will utilize the ambient AI scribe tools from Abridge. They will otherwise continue their usual clinical activities, including providing care with trainees (e.g., medical students, residents) and multiple family members in the room. The tool will be used exclusively in the outpatient clinical setting and only when the participant is present. The ambient AI scribe tool integrates into the electronic health record (EHR), and the EHR's mobile app is used to collect the recording on a mobile device. The ambient AI scribe tool is transcriptional and does not provide clinical decision support.
- interventionNames
- Other: Use of Ambient AI scribe tool on participant's mobile device
- type
- NO_INTERVENTION
- label
- Routine patient care (no AI scribe)
- description
- These participants were not provided with the ambient AI scribe application on their mobile device. They still had access to documentation with dictation or existing scribe services (non-AI).
Primary outcomes (3)
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Provider is an employee of the University of Washington Medicine. * Clinical specialty of primary care, oncology, or urology. * Clinical full-time equivalent (FTE) of 0.2 or greater (provider must have an outpatient clinic of at least 20% of an FTE). * Provider is a physician or an advanced practice provider. Exclusion Criteria: * Trainees (e.g., medical students, residents, or fellows) * Provider does not have access to a mobile device that is compatible with the ambient AI scribe service (e.g., Android mobile phone).
References
Publications (0)
Data not yet available